Nrf2 activator-9 (compound D-36) is an agent that mitigates oxidative stress by inhibiting the apoptosis of HUVEC cells induced by oxidized low-density lipoprotein (oxLDL) and high glucose (HG), also protecting vascular endothelial cells (VEC) from oxLDL and HG-induced injury, offering potential therapeutic benefits for atherosclerosis prevention and treatment [1].
Molecular Weight:
473.52
Formula:
C26H27N5O4
Target:
Apoptosis|||Others|||Nrf2
* VAT and and shipping costs not included. Errors and price changes excepted
